Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $3.8 million.

  • IceCure Medical's Net Income towards Common Stockholders fell 1064.52% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 560.13%. This contributed to the annual value of $15.7 million for FY2024, which is 77.04% up from last year.
  • Latest data reveals that IceCure Medical reported Net Income towards Common Stockholders of $3.8 million as of Q3 2025, which was down 1064.52% from $3.4 million recorded in Q2 2025.
  • IceCure Medical's Net Income towards Common Stockholders' 5-year high stood at $4.5 million during Q4 2024, with a 5-year trough of -$29.5 million in Q4 2022.
  • Over the past 5 years, IceCure Medical's median Net Income towards Common Stockholders value was $3.7 million (recorded in 2025), while the average stood at $806789.5.
  • In the last 5 years, IceCure Medical's Net Income towards Common Stockholders tumbled by 12976.21% in 2021 and then skyrocketed by 33379.31% in 2022.
  • Over the past 5 years, IceCure Medical's Net Income towards Common Stockholders (Quarter) stood at -$16.3 million in 2021, then crashed by 81.04% to -$29.5 million in 2022, then skyrocketed by 111.56% to $3.4 million in 2023, then skyrocketed by 32.5% to $4.5 million in 2024, then fell by 15.23% to $3.8 million in 2025.
  • Its Net Income towards Common Stockholders was $3.8 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.7 million in Q1 2025.